Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00486980 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

StatusWithdrawn
PhasePhase 3
View on ClinicalTrials.gov ↗
Why the trial stopped
This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".

Record History

  1. Enrollment target: 0v4
  2. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.
Trial Details
NCT Number NCT00486980
Lead Sponsor BioCryst Pharmaceuticals
Conditions Influenza
Updated on ClinicalTrials.gov